首页 | 本学科首页   官方微博 | 高级检索  
检索        


Topical glaucoma medications – Clinical implications for the ocular surface
Institution:1. Department of Medical Biochemistry, Oslo University Hospital, Norway;2. The Norwegian Dry Eye Clinic, Ole Vigs gate 32 E, 0366, Oslo, Norway;3. Department of Computer Science, Oslo Metropolitan University, Norway;4. SimulaMet, Oslo, Norway;5. Department of Ophthalmology, Itoh Clinic, Saitama, Japan;6. Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark;7. Department of Ophthalmology, Copenhagen University Hospital, Rigshospitalet, Glostrup, Denmark;8. Department of Twin Research & Genetic Epidemiology, King''s College London, St Thomas'' Hospital, London, United Kingdom;9. Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands;10. Department of Ophthalmology, Stavanger University Hospital, Norway;11. Department of Ophthalmology, Vestre Viken Hospital, Drammen, Norway;12. Department of Ophthalmology, Vestfold Hospital, Tønsberg, Norway;13. Department of Clinical Medicine, Faculty of Medicine, University of Bergen, Bergen, Norway;14. Department of Ophthalmology, Oslo University Hospital, Norway;15. Department of Research and Development, Oslo Metropolitan University, Oslo, Norway;p. Department of Quality and Health Technology, The Faculty of Health Sciences, University of Stavanger, Stavanger, Norway;q. Department of Oral Biology, Faculty of Dentistry, University of Oslo, Oslo, Norway;r. National Centre for Optics, Vision and Eye Care, Department of Optometry, Radiography and Lighting Design, Faculty of Health Sciences, University of South-Eastern Norway, Kongsberg, Norway;s. Department of Health and Nursing Science, The Faculty of Health and Sport Sciences, University of Agder, Grimstad, Norway;t. Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden;u. Department of Ophthalmology, Sørlandet Hospital Arendal, Norway
Abstract:Glaucoma is a leading cause of irreversible blindness. The use of topical eye drops to reduce intraocular pressure remains the mainstay treatment. These eye drops frequently contain preservatives designed to ensure sterility of the compound. A growing number of clinical and experimental studies report the detrimental effects of not only these preservatives but also the active pharmaceutical compounds on the ocular surface, with resultant tear film instability and dry eye disease. Herein, we critically appraise the published literature exploring the effects of preservatives and pharmaceutical compounds on the ocular surface.
Keywords:Dry eye disease  Eyedrops  Glaucoma  Meibomian gland dysfunction  Topical medications
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号